Skip to content

To study the efficacy of Amalaki siddha Goghrita Aschyotana in the Management of Vernal Keratoconjunctivitis

The Efficacy of Amalaki siddha Goghrita Aschyotana in the Management of Vernal Keratoconjunctivitis

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/06/043356
Enrollment
60
Registered
2022-06-20
Start date
Unknown
Completion date
Unknown
Last updated
2022-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H108- Other conjunctivitis

Interventions

None listed

Sponsors

Dr Shruti Mohan Phadke
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient suffering from Vernal keratoconjunctivitis, of age group (above 4 years to 20 years) irrespective of gender and occupation is included.

Exclusion criteria

Exclusion criteria: 1.Existing ocular surface pathology. 2.One eyed patients. 3.Patients below 4 years of age and above 20 years of age. 4.Existing ocular infections.

Design outcomes

Primary

MeasureTime frame
To prevent recurrence of conjunctivitis, and minimal use of steroidsTimepoint: 14 days study with 3 follow-ups (0th, 7th, 14th day)

Secondary

MeasureTime frame
Significant reduction in all symptoms of Vernal keratoconjunctivitis and avoid recurrence of vkcTimepoint: 14 days study with 3 follow ups (0, 7th and 14th day)

Countries

India

Contacts

Public ContactDr Shruti Mohan Phadke

Bharti vidyapeeth (deemed to be university) College of Ayurved and hospital Pune

drgajananpatil1984@gmail.com9923037117

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026